• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Pragmatic Free Trial Meta

Pragmatic Free Trial Meta is a non-commercial open data platform and infrastructure that supports research on pragmatic trials. It collects and shares cleaned trial data and ratings using PRECIS-2 permitting multiple and varied meta-epidemiological studies that evaluate the effect of treatment on trials that employ different levels of pragmatism, as well as other design features.

Background

Pragmatic trials provide evidence from the real world that can be used to make clinical decisions. The term "pragmatic", however, is a word that is often used in contradiction and its definition and measurement require clarification. Pragmatic trials must be designed to guide clinical practice and policy decisions, rather than confirm the validity of a clinical or physiological hypothesis. A pragmatic study should strive to be as close to actual clinical practice as possible, including in its recruitment of participants, setting up and design of the intervention, its delivery and implementation of the intervention, determination and analysis of outcomes as well as primary analyses. This is a significant difference between explanatory trials, as described by Schwartz & Lellouch1, which are designed to test a hypothesis in a more thorough manner.

The trials that are truly pragmatic should avoid attempting to blind participants or the clinicians in order to result in bias in the estimation of the effect of treatment. Pragmatic trials will also recruit patients from different health care settings to ensure that their results can be generalized to the real world.

Additionally, pragmatic trials should focus on outcomes that are crucial to patients, such as quality of life or functional recovery. This is especially important when trials involve surgical procedures that are invasive or may have dangerous adverse consequences. The CRASH trial29 compared a 2-page report with an electronic monitoring system for hospitalized patients with chronic cardiac failure. The trial with a catheter, however, used symptomatic catheter associated urinary tract infection as its primary outcome.

In addition to these aspects, pragmatic trials should minimize the requirements for data collection and trial procedures to reduce costs and time commitments. Finaly, pragmatic trials should aim to make their results as relevant to actual clinical practices as possible. This can be accomplished by ensuring that their analysis is based on an intention-to treat method (as defined in CONSORT extensions).

Despite these criteria, many RCTs with features that defy pragmatism have been incorrectly self-labeled pragmatic and published in journals of all kinds. This can lead to misleading claims of pragmatism, and the term's use should be standardized. The creation of a PRECIS-2 tool that provides an objective and standardized evaluation of pragmatic aspects is a first step.

Methods

In a pragmatic study it is the intention to inform clinical or policy decisions by showing how an intervention could be integrated into routine care in real-world settings. Explanatory trials test hypotheses about the cause-effect relation within idealized settings. In this way, 프라그마틱 추천 pragmatic trials can have lower internal validity than studies that explain and be more prone to biases in their design as well as analysis and conduct. Despite these limitations, pragmatic trials can provide valuable information to decision-making in healthcare.

The PRECIS-2 tool assesses the degree of pragmatism in an RCT by assessing it on 9 domains, ranging from 1 (very explicative) to 5 (very pragmatic). In this study the areas of recruitment, 프라그마틱 추천 organisation, flexibility in delivery, flexibility in adherence, and follow-up were awarded high scores. However, the main outcome and method of missing data was scored below the pragmatic limit. This indicates that a trial can be designed with effective pragmatic features, without damaging the quality.

However, it is difficult to judge how pragmatic a particular trial really is because pragmatism is not a binary quality; certain aspects of a trial may be more pragmatic than others. A trial's pragmatism could be affected by changes to the protocol or the logistics during the trial. Koppenaal and colleagues found that 36% of the 89 pragmatic studies were placebo-controlled or conducted prior to the licensing. Most were also single-center. Therefore, they aren't as common and can only be called pragmatic if their sponsors are tolerant of the lack of blinding in such trials.

A typical feature of pragmatic studies is that researchers attempt to make their findings more meaningful by studying subgroups of the trial sample. However, this can lead to unbalanced comparisons and lower statistical power, thereby increasing the risk of either not detecting or incorrectly detecting differences in the primary outcome. This was a problem in the meta-analysis of pragmatic trials as secondary outcomes were not adjusted for covariates that differed at baseline.

Furthermore, pragmatic studies can pose difficulties in the collection and interpretation of safety data. This is because adverse events are typically reported by participants themselves and are susceptible to reporting delays, inaccuracies or coding errors. It is crucial to improve the quality and accuracy of the outcomes in these trials.

Results

Although the definition of pragmatism may not require that all trials be 100 100% pragmatic, there are advantages to incorporating pragmatic components into clinical trials. These include:

Increased sensitivity to real-world issues which reduces the size of studies and their costs, and enabling the trial results to be faster transferred into real-world clinical practice (by including routine patients). But pragmatic trials can have disadvantages. The right type of heterogeneity for instance could allow a study to extend its findings to different patients or settings. However the wrong type of heterogeneity could decrease the sensitivity of the test and thus reduce a trial's power to detect even minor effects of treatment.

Several studies have attempted to categorize pragmatic trials using various definitions and 프라그마틱 정품확인 무료 (Https://Telegra.ph) scoring methods. Schwartz and Lellouch1 created a framework to distinguish between explanatory trials that confirm a clinical or physiological hypothesis, and pragmatic trials that help in the selection of appropriate treatments in clinical practice. The framework was composed of nine domains evaluated on a scale of 1-5, with 1 being more explanatory while 5 was more pragmatic. The domains covered recruitment of intervention, setting up, delivery of intervention, flex adhering to the program and primary analysis.

The original PRECIS tool3 had similar domains and an assessment scale ranging from 1 to 5. Koppenaal et al10 devised an adaptation of this assessment, dubbed the Pragmascope that was simpler to use in systematic reviews. They found that pragmatic reviews scored higher on average in all domains, but scored lower in the primary analysis domain.

The difference in the main analysis domain could be explained by the fact that the majority of pragmatic trials analyze their data in the intention to treat method, whereas some explanatory trials do not. The overall score was lower for pragmatic systematic reviews when the domains of organisation, flexible delivery, and follow-up were combined.

It is important to remember that the term "pragmatic trial" does not necessarily mean a low-quality trial, and in fact there is an increasing number of clinical trials (as defined by MEDLINE search, however this is neither specific nor sensitive) which use the word "pragmatic" in their abstract or title. The use of these terms in abstracts and titles may suggest a greater awareness of the importance of pragmatism but it is unclear whether this is evident in the content of the articles.

Conclusions

In recent times, pragmatic trials are becoming more popular in research as the importance of real-world evidence is becoming increasingly acknowledged. They are randomized trials that evaluate real-world care alternatives to experimental treatments in development. They include patient populations more closely resembling those treated in regular care. This approach has the potential to overcome the limitations of observational studies, such as the limitations of relying on volunteers and the lack of accessibility and coding flexibility in national registries.

Pragmatic trials offer other advantages, like the ability to use existing data sources and a greater probability of detecting meaningful differences than traditional trials. However, they may be prone to limitations that compromise their credibility and generalizability. The participation rates in certain trials could be lower than expected because of the healthy-volunteering effect, financial incentives or competition from other research studies. Practical trials are often limited by the need to recruit participants on time. Some pragmatic trials also lack controls to ensure that the observed variations aren't due to biases that occur during the trial.

The authors of the Pragmatic Free Trial Meta identified RCTs that were published between 2022 and 2022 that self-described as pragmatism. They assessed pragmatism by using the PRECIS-2 tool, which includes the domains eligibility criteria and recruitment criteria, as well as flexibility in adherence to interventions, and follow-up. They found 14 trials scored highly pragmatic or pragmatic (i.e. scoring 5 or 프라그마틱 슬롯 무료 슬롯 추천 (Historydb.date) higher) in at least one of these domains.

Trials with a high pragmatism rating tend to have higher eligibility criteria than traditional RCTs that have specific criteria that are unlikely to be found in clinical practice, and they comprise patients from a wide range of hospitals. According to the authors, can make pragmatic trials more relevant and relevant to everyday practice. However, they don't guarantee that a trial is free of bias. Moreover, the pragmatism of a trial is not a definite characteristic and a pragmatic trial that does not have all the characteristics of a explanatory trial can produce valid and useful results.